Saint Luke’s Cancer Institute announced an affiliation with Washington University School of Medicine in St. Louis effective June 1, 2017, giving Saint Luke’s cancer patients expanded access to clinical trials beginning in late summer.
Saint Luke’s Cancer Institute is part of Saint Luke’s Health System which consists of 10 hospitals and campuses in the Kansas City area and the surrounding region.
By law, the Food and Drug Administration is required to determine whether a drug, device, biologic, or medical device is “safe and effective.” But the FDA determination does not control whether the Centers for Medicare & Medicaid Services will pay for it. To satisfy CMS, medical products and services must be “reasonable and necessary,” meaning...
As a radiation oncologist, I am struck by how often the decisive variable in lung cancer is not the sophistication of our therapy, but the timing of our encounter with the disease. The American Cancer Society projects 618,120 cancer deaths in the United States in 2025, with lung cancer remaining as the single largest contributor,...
